Botulinum toxin A treatment of Raynaud's phenomenon: a review.


OBJECTIVES Botulinum toxin A has conventionally been used in the upper extremity to treat spasticity resulting from stroke, paraplegia, and dystonia. Recently, it has been used to relieve symptoms of vasospasm in Raynaud's phenomenon. This review summarizes the current literature on botulinum toxin A in the treatment of Raynaud's phenomenon and examines the… (More)
DOI: 10.1016/j.semarthrit.2011.07.006


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics